Abstract
Following globe removal, the surgeon must determine the best orbital implant to place into the anophthalmic socket. A decision on appropriate implant size, whether to place a porous or nonporous implant, and a patient’s total clinical picture must be considered to prevent future complications. Other considerations, including whether to wrap an implant and place a motility peg, must also be made. The modern implant is built on the foundation of anophthalmic socket reconstruction—implant retention, volume replacement, and adequate prosthetic motility. This chapter will review the special considerations the ophthalmic surgeon must weigh when choosing an orbital implant following enucleation and evisceration surgeries.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Burch FE. Evisceration of the globe with scleral implant and preservation of the cornea. Trans Am Ophthalmol Soc. 1939;37:272–82.
Luce CM. A short history of enucleation. Int Ophthalmol Clin. 1970;10(4):681–7.
Mules PH. Evisceration of the globe with artificial vitreous. 1884–1895. Adv Ophthalmic Plast Reconstr Surg. 1990;8:69–72.
Berens C. Enucleation with implantation of foreign substances into Tenon’s capsule: a technique in which no sutures are buried. Am J Ophthalmol. 1937;20(3):293–6.
Lang W. On the insertion of artificial globes into Tenon’s capsule after excising the eye. Trans Ophth Soc UK. 1887;7:286.
Wheeler JM. Implantation of hollow grooved body into orbit for filling: late after enucleation of eyeball. Arch Ophthalmol. 1938;20(5):709–12.
Allen JH, Allen L. A buried muscle cone implant. Development of a tunneled hemispherical type. Arch Ophthalmol. 1950;43(5):879–90.
Cutler NL. A positive contact ball and ring implant for use after enucleation. Arch Ophthalmol. 1947;37(1):73–81.
Mules PH. Evisceration of the eye, and its relation to the bacterial theory of the origin of sympathetic disease. Br Med J. 1886;1(1310):246–7.
Shields CL, Shields JA, De Potter P, Singh AD. Problems with the hydroxyapatite orbital implant: experience with 250 consecutive cases. Br J Ophthalmol. 1994;78(9):702–6.
Kaltreider SA, Newman SA. Prevention and management of complications associated with the hydroxyapatite implant. Ophthalmic Plast Reconstr Surg. 1996;12(1):18–31.
Custer PL, Trinkaus KM. Volumetric determination of enucleation implant size. Am J Ophthalmol. 1999;128(4):489–94.
Tyers AG, Collin JR. Baseball orbital implants: a review of 39 patients. Br J Ophthalmol. 1985;69(6):438–42.
Bentley RP, Sgouros S, Natarajan K, Dover MS, Hockley AD. Normal changes in orbital volume during childhood. J Neurosurg. 2002;96(4):742–6.
Yoon JS, Lew H, Kim SJ, Lee SY. Exposure rate of hydroxyapatite orbital implants a 15-year experience of 802 cases. Ophthalmology. 2008;115(3):566–72 e2.
Remulla HD, Rubin PA, Shore JW, Sutula FC, Townsend DJ, Woog JJ, et al. Complications of porous spherical orbital implants. Ophthalmology. 1995;102(4):586–93.
Trichopoulos N, Augsburger JJ. Enucleation with unwrapped porous and nonporous orbital implants: a 15-year experience. Ophthalmic Plast Reconstr Surg. 2005;21(5):331–6.
Colen TP, Paridaens DA, Lemij HG, Mourits MP, van Den Bosch WA. Comparison of artificial eye amplitudes with acrylic and hydroxyapatite spherical enucleation implants. Ophthalmology. 2000;107(10):1889–94.
Custer PL, Trinkaus KM, Fornoff J. Comparative motility of hydroxyapatite and alloplastic enucleation implants. Ophthalmology. 1999;106(3):513–6.
Su GW, Yen MT. Current trends in managing the anophthalmic socket after primary enucleation and evisceration. Ophthalmic Plast Reconstr Surg. 2004;20(4):274–80.
Lyle CE, Wilson MW, Li CS, Kaste SC. Comparison of orbital volumes in enucleated patients with unilateral retinoblastoma: hydroxyapatite implants versus silicone implants. Ophthalmic Plast Reconstr Surg. 2007;23(5):393–6.
Wells TS, Harris GJ. Direct fixation of extraocular muscles to a silicone sphere: a cost-sensitive, low-risk enucleation procedure. Ophthalmic Plast Reconstr Surg. 2011;27(5):364–7.
Spivey BE, Allen L, Burns CA. The Iowa enucleation implant. A 10-year evaluation of technique and results. Am J Ophthalmol. 1969;67(2):171–88.
Karsloglu S, Serin D, Simsek I, Ziylan S. Implant infection in porous orbital implants. Ophthalmic Plast Reconstr Surg. 2006;22(6):461–6.
Chuo JY, Dolman PJ, Ng TL, Buffam FV, White VA. Clinical and histopathologic review of 18 explanted porous polyethylene orbital implants. Ophthalmology. 2009;116(2):349–54.
Custer PL, Trinkaus KM. Porous implant exposure: incidence, management, and morbidity. Ophthalmic Plast Reconstr Surg. 2007;23(1):1–7.
Dutton JJ. Coralline hydroxyapatite as an ocular implant. Ophthalmology. 1991;98(3):370–7.
Perry AC. Integrated orbital implants. Adv Ophthalmic Plast Reconstr Surg. 1990;8:75–81.
Shields CL, Shields JA, De Potter P, Singh AD. Lack of complications of the hydroxyapatite orbital implant in 250 consecutive cases. Trans Am Ophthalmol Soc. 1993;91:177–89; discussion 89–95.
Nunery WR, Heinz GW, Bonnin JM, Martin RT, Cepela MA. Exposure rate of hydroxyapatite spheres in the anophthalmic socket: histopathologic correlation and comparison with silicone sphere implants. Ophthalmic Plast Reconstr Surg. 1993;9(2):96–104.
Klapper SR, Jordan DR, Brownstein S, Punja K. Incomplete fibrovascularization of a hydroxyapatite orbital implant 3 months after implantation. Arch Ophthalmol. 1999;117(8):1088–9.
Rosner M, Edward DP, Tso MO. Foreign-body giant-cell reaction to the hydroxyapatite orbital implant. Arch Ophthalmol. 1992;110(2):173–4.
Goldberg RA, Holds JB, Ebrahimpour J. Exposed hydroxyapatite orbital implants. Report of six cases. Ophthalmology. 1992;99(5):831–6.
Jordan DR, Hwang I, Brownstein S, McEachren T, Gilberg S, Grahovac S, et al. The molteno m-sphere. Ophthalmic Plast Reconstr Surg. 2000;16(5):356–62.
Jordan DR, Munro SM, Brownstein S, Gilberg SM, Grahovac SZ. A synthetic hydroxyapatite implant: the so-called counterfeit implant. Ophthalmic Plast Reconstr Surg. 1998;14(4):244–9.
Celik T, Yuksel D, Kosker M, Kasim R, Simsek S. Vascularization of coralline versus synthetic hydroxyapatite orbital implants assessed by gadolinium enhanced magnetic resonance imaging. Curr Eye Res. 2015;40(3):346–53.
Karesh JW, Dresner SC. High-density porous polyethylene (Medpor) as a successful anophthalmic socket implant. Ophthalmology. 1994;101(10):1688–95; discussion 95–6.
Hornblass A, Biesman BS, Eviatar JA. Current techniques of enucleation: a survey of 5,439 intraorbital implants and a review of the literature. Ophthalmic Plast Reconstr Surg. 1995;11(2):77–86; discussion 7–8.
Jordan DR, Mawn LA, Brownstein S, McEachren TM, Gilberg SM, Hill V, et al. The bioceramic orbital implant: a new generation of porous implants. Ophthalmic Plast Reconstr Surg. 2000;16(5):347–55.
Badilla J, Dolman PJ. Methods of antibiotic instillation in porous orbital implants. Ophthalmic Plast Reconstr Surg. 2008;24(4):287–9.
Buettner H, Bartley GB. Tissue breakdown and exposure associated with orbital hydroxyapatite implants. Am J Ophthalmol. 1992;113(6):669–73.
Li T, Shen J, Duffy MT. Exposure rates of wrapped and unwrapped orbital implants following enucleation. Ophthalmic Plast Reconstr Surg. 2001;17(6):431–5.
Christmas NJ, Van Quill K, Murray TG, Gordon CD, Garonzik S, Tse D, et al. Evaluation of efficacy and complications: primary pediatric orbital implants after enucleation. Arch Ophthalmol. 2000;118(4):503–6.
Seiff SR, Chang JS Jr, Hurt MH, Khayam-Bashi H. Polymerase chain reaction identification of human immunodeficiency virus-1 in preserved human sclera. Am J Ophthalmol. 1994;118(4):528–30.
Jordan DR, Allen LH, Ells A, Gilberg S, Brownstein S, Munro S, et al. The use of Vicryl mesh (polyglactin 910) for implantation of hydroxyapatite orbital implants. Ophthalmic Plast Reconstr Surg. 1995;11(2):95–9.
Jongman HP, Marinkovic M, Notting I, Koetsier L, Swart W, Schalij-Delfos NE, et al. Donor sclera-wrapped acrylic orbital implants following enucleation: experience in 179 patients in the Netherlands. Acta Ophthalmol. 2016;94(3):253–6.
Suter AJ, Molteno AC, Bevin TH, Fulton JD, Herbison P. Long term follow up of bone derived hydroxyapatite orbital implants. Br J Ophthalmol. 2002;86(11):1287–92.
Blaydon SM, Shepler TR, Neuhaus RW, White WL, Shore JW. The porous polyethylene (Medpor) spherical orbital implant: a retrospective study of 136 cases. Ophthalmic Plast Reconstr Surg. 2003;19(5):364–71.
Jordan DR, Klapper SR. A new titanium peg system for hydroxyapatite orbital implants. Ophthalmic Plast Reconstr Surg. 2000;16(5):380–7.
Rokohl AC, Koch KR, Trester M, Trester W, Pine KR, Heindl LM. Concerns of anophthalmic patients wearing cryolite glass prosthetic eyes. Ophthalmic Plast Reconstr Surg. 2018;34(4):369–74.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Rong, A.J., Johnson, T.E. (2020). Orbital Implants and Wrapping Materials. In: Johnson, T. (eds) Anophthalmia . Springer, Cham. https://doi.org/10.1007/978-3-030-29753-4_9
Download citation
DOI: https://doi.org/10.1007/978-3-030-29753-4_9
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-29752-7
Online ISBN: 978-3-030-29753-4
eBook Packages: MedicineMedicine (R0)